VolitionRx Limited Impairment of Intangible Assets, Finite-lived
VolitionRx Limited (VNRX) reported Impairment of Intangible Assets, Finite-lived of $350.00 thousand for the 47-month period ending 2014-06-30, per its 10-Q filed 2014-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2015-03-18
- VolitionRx Limited impairment of intangible assets, finite-lived for fiscal 2013 was $350.00K.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 41 month | Impairment of Intangible Assets, Finite-lived 44 month | Impairment of Intangible Assets, Finite-lived 47 month |
|---|---|---|---|---|
| 2014-06-30 | $350.00K 10-Q · filed 2014-08-01 | |||
| 2014-03-31 | $350.00K 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | $350.00K 10-K · filed 2015-03-18 | $350.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |